Can You Pass the (Deoxyribonucleic) Acid Test?
By Center for Environmental Health,
Center for Environmental Health [with CGS's Pete Shanks]
| 03. 17. 2014
For just $99, genetic test company 23andme offered to test your DNA for everything from heart disease risk to your chance of going bald. Kira Peikoff wondered what DNA testing from 23andme and two other companies would tell her—and the results were surprising. We’ll also talk to geneticist Dr. David Ng. His story in McSweeny’s, “Congratulations, Your Ineffectual Genetic Test Results Have Arrived” pokes fun at the “direct-to-consumer” genetic testing industry. Then Dr. Stuart Newman fills us in on epigenetics, evolutionary developmental biology, and why the Lamarck versus Darwin debate may be old news. Finally, advocate Pete Shanks on the “promise” of GMO humans and the threat of techno-eugenics.
Check out this episode.
Download here, or subscribe via iTunes.
Kira Peikoff is an author and Masters student in bioethics at Columbia University. Her New York Times article in December exposed the fallacies of direct-to-consumer genetic testing (see more resources on genetic test companies below). Check out her debut novel Living Proof (and look for her upcoming 2nd novel in the fall) on her website.
David Ng is...
Related Articles
By Josie Ensor, The Times | 12.09.2025
A fertility start-up that promises to screen embryos to give would-be parents their “best baby” has come under fire for a “misuse of science”.
Nucleus Genomics describes its mission as “IVF for genetic optimisation”, offering advanced embryo testing that allows...
By Hannah Devlin, The Guardian | 12.06.2025
Couples undergoing IVF in the UK are exploiting an apparent legal loophole to rank their embryos based on genetic predictions of IQ, height and health, the Guardian has learned.
The controversial screening technique, which scores embryos based on their DNA...
By Frankie Fattorini, Pharmaceutical Technology | 12.02.2025
Próspera, a charter city on Roatán island in Honduras, hosts two biotechs working to combat ageing through gene therapy, as the organisation behind the city advertises its “flexible” regulatory jurisdiction to attract more developers.
In 2021, Minicircle set up a...
By Vardit Ravitsky, The Hastings Center | 12.04.2025
Embryo testing is advancing fast—but how far is too far? How and where do we draw the line between preventing disease and selecting for “desirable” traits? What are the ethical implications for parents, children, clinicians, and society at large? These...
